Disclosures for "Minimal Symptom Expression with Claseprubart, an Active C1S Inhibitor, in Patients with Generalized Myasthenia Gravis"
-
Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
-
Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Gilhus has received personal compensation in the range of $0-$499 for serving as a Consultant for Immunovant. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denka. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Gilhus has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Prof. Gilhus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Gilhus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Alexion, UCB, Johnson & Johnson, Dianthus, Amgen. Prof. Gilhus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
-
Dr. Sachdev has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Sachdev has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sachdev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Sachdev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Sachdev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Sachdev has received research support from UCB. The institution of Dr. Sachdev has received research support from argenx. The institution of Dr. Sachdev has received research support from Alexion Pharmaceuticals. The institution of Dr. Sachdev has received research support from Immunovant. The institution of Dr. Sachdev has received research support from Dianthus.
-
Dr. Ait Tihyaty has received personal compensation for serving as an employee of Dianthus Therapeutics.
-
Dr. Briggs has received personal compensation for serving as an employee of Dianthus Therapeutics. Dr. Briggs has stock in Dianthus Therapeutics.
-
Dr. Siddiqui has or had stock in Dianthus Therapeutics.
-
Mr. Hickey has received personal compensation for serving as an employee of Dianthus Therapeutics. Mr. Hickey has or had stock in Dianthus Therapeutics.
-
Dr. Lalla has nothing to disclose.
-
Dr. Smilowski has nothing to disclose.